Shortlist

EV/EBIT of 7.4 against a Financial Services median of 8.0 — 6% below peers. Free cash flow yield 11.1%. Trading 81% below its all-time high set 2021-07-23.

At the Financial Services median EV/EBIT of 8.0 instead of its current 7.4, and with earnings unchanged, the equity would be worth about 7% more. That is the size of the gap, not a forecast that it closes.

• ROIC 28% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 9/9 — accounts improving year on year
• revenue compounding at 6% over three years
• net debt -0.1x EBITDA — balance sheet not forcing anything

Consensus hold from 33 analysts, mean target 58.83 USD, 0% below the current price. Revisions over the last quarter have been net positive, which is the part of analyst output the evidence actually supports.

Targets spread 189% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Trading 0% above the consensus target — the sell side thinks it is expensive.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

EV/EBIT of 11.7 against a Technology median of 47.1 — 75% below peers. Free cash flow yield 9.3%. Trading 61% below its all-time high set 2021-11-19.

At the Technology median P/E of 56.7 instead of its current 14.8, and with earnings unchanged, the equity would be worth about 283% more. That is the size of the gap, not a forecast that it closes.

• ROIC 63% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• revenue compounding at 11% over three years
• net debt 0.0x EBITDA — balance sheet not forcing anything

Consensus hold from 34 analysts, mean target 269.61 USD, 2% above the current price. Revisions over the last quarter have been net negative — the sell side is marking this down.

Targets spread 70% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

EV/EBIT of 5.6 against a Financial Services median of 8.0 — 29% below peers. Free cash flow yield 16.4%.

At the Financial Services median EV/EBIT of 8.0 instead of its current 5.6, and with earnings unchanged, the equity would be worth about 35% more. That is the size of the gap, not a forecast that it closes.

• ROIC 54% — still earning above a plausible cost of capital
• free cash flow positive
• revenue compounding at 31% over three years
• operating margin 19%

mean target 150.00 ILS, 14% below the current price. Revisions over the last quarter are balanced.

Only 1 analyst estimate(s) — too few for a consensus to mean much.

Trading 14% above the consensus target — the sell side thinks it is expensive.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 15.0 against a Healthcare median of 22.1 — 32% below peers. Free cash flow yield 7.6%.

At the Healthcare median EV/EBIT of 22.1 instead of its current 15.0, and with earnings unchanged, the equity would be worth about 60% more. That is the size of the gap, not a forecast that it closes.

• ROIC 15% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 9/9 — accounts improving year on year
• operating margin 23%

Consensus buy from 24 analysts, mean target 66.21 USD, 2% above the current price. Revisions over the last quarter have been net positive, which is the part of analyst output the evidence actually supports.

Targets spread 60% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

P/E of 11.1 against a Financial Services median of 13.2 — 16% below peers. Free cash flow yield 15.3%.

At the Financial Services median EV/EBIT of 8.0 instead of its current 7.7, and with earnings unchanged, the equity would be worth about 2% more. That is the size of the gap, not a forecast that it closes.

• ROIC 66% — still earning above a plausible cost of capital
• free cash flow positive
• revenue compounding at 21% over three years
• operating margin 17%

Consensus hold from 21 analysts, mean target 229.78 USD, 7% above the current price. Revisions over the last quarter are balanced.

Targets spread 48% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

EV/EBIT of 17.9 against a Technology median of 47.1 — 62% below peers. Free cash flow yield 6.7%. Trading 59% below its all-time high set 2025-07-30.

At the Technology median EV/EBIT of 47.1 instead of its current 17.9, and with earnings unchanged, the equity would be worth about 167% more. That is the size of the gap, not a forecast that it closes.

• ROIC 19% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 9/9 — accounts improving year on year
• revenue compounding at 14% over three years
• net debt 0.4x EBITDA — balance sheet not forcing anything

Consensus buy from 33 analysts, mean target 454.65 USD, 40% above the current price. Revisions over the last quarter have been net negative — the sell side is marking this down.

Targets spread 148% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 6.4 against a Financial Services median of 8.0 — 19% below peers. Free cash flow yield 7.7%.

At the Financial Services median EV/EBIT of 8.0 instead of its current 6.4, and with earnings unchanged, the equity would be worth about 35% more. That is the size of the gap, not a forecast that it closes.

• ROIC 14% — still earning above a plausible cost of capital
• free cash flow positive
• revenue compounding at 46% over three years
• operating margin 19%

mean target 290.00 ILS, 28% above the current price. Revisions over the last quarter are balanced.

Only 1 analyst estimate(s) — too few for a consensus to mean much.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

EV/EBIT of 9.6 against a Technology median of 47.1 — 80% below peers. Free cash flow yield 10.4%. Trading 55% below its all-time high set 2025-02-05.

No usable re-rating gap: the multiple is at or above its sector median, or the inputs were missing.

• ROIC 30% — still earning above a plausible cost of capital
• free cash flow positive
• net debt -0.3x EBITDA — balance sheet not forcing anything
• Altman Z 4.1 — outside the distress zone
• operating margin 16%

Consensus buy from 25 analysts, mean target 178.89 USD, 2% above the current price. Revisions over the last quarter have been net negative — the sell side is marking this down.

Targets spread 81% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 16.7 against a Technology median of 47.1 — 64% below peers. Free cash flow yield 9.6%. Trading 41% below its all-time high set 2026-01-14.

At the Technology median EV/EBIT of 47.1 instead of its current 16.7, and with earnings unchanged, the equity would be worth about 186% more. That is the size of the gap, not a forecast that it closes.

• ROIC 28% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 9/9 — accounts improving year on year
• revenue compounding at 10% over three years
• net debt 0.3x EBITDA — balance sheet not forcing anything

mean target 120.00 ILS, 36% above the current price. Revisions over the last quarter are balanced.

Only 1 analyst estimate(s) — too few for a consensus to mean much.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 10.1 against a Basic Materials median of 26.6 — 62% below peers. Free cash flow yield 6.3%.

At the Basic Materials median EV/EBIT of 26.6 instead of its current 10.1, and with earnings unchanged, the equity would be worth about 161% more. That is the size of the gap, not a forecast that it closes.

• ROIC 22% — still earning above a plausible cost of capital
• free cash flow positive
• Piotroski F-Score 9/9 — accounts improving year on year
• revenue compounding at 24% over three years
• net debt -0.2x EBITDA — balance sheet not forcing anything

Consensus buy from 21 analysts, mean target 130.36 USD, 15% above the current price. Revisions over the last quarter have been net positive, which is the part of analyst output the evidence actually supports.

Targets spread 77% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

Read off the statements over three years, not from any view about the company's prospects. What the numbers cannot tell you is whether management already has an answer.

Trading 38% below its all-time high set 2025-01-22.

No usable re-rating gap: the multiple is at or above its sector median, or the inputs were missing.

• free cash flow positive
• Piotroski F-Score 7/9 — accounts improving year on year
• revenue compounding at 17% over three years
• Altman Z 32.8 — outside the distress zone
• operating margin 29%

Consensus buy from 29 analysts, mean target 477.25 USD, 26% above the current price. Revisions over the last quarter have been net negative — the sell side is marking this down.

Targets spread 76% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.

EV/EBIT of 13.6 against a Technology median of 47.1 — 71% below peers. Free cash flow yield 7.1%. Trading 33% below its all-time high set 2026-05-29.

At the Technology median EV/EBIT of 47.1 instead of its current 13.6, and with earnings unchanged, the equity would be worth about 253% more. That is the size of the gap, not a forecast that it closes.

• ROIC 23% — still earning above a plausible cost of capital
• free cash flow positive
• net debt 0.3x EBITDA — balance sheet not forcing anything
• Altman Z 6.4 — outside the distress zone
• operating margin 30%

Consensus hold from 30 analysts, mean target 194.77 USD, 16% above the current price. Revisions over the last quarter have been net positive, which is the part of analyst output the evidence actually supports.

Targets spread 154% of the mean — analysts disagree sharply, and consensus loses its information content when they do.

Price target levels are shown as context only and never feed the score. Targets are reached roughly half the time and the most optimistic ones tend to underperform. Revision direction is the part that carries information.